×

To enhance security, Multi-Factor Authentication (MFA) is mandatory for all HL7 users. More information

Section 1c: FHIR®
Section 3: Implementation Guides
Section 4: Rules and References

HL7 FHIR® Implementation Guide: Continuous Glucose Monitoring (CGM), Edition 1

DESCRIPTION

The Continuous Glucose Monitoring Implementation Guide provides a standardized approach for sharing Continuous Glucose Monitoring (CGM) data between actors. This Implementation Guide (IG) focuses on enabling the exchange of CGM data, including high-level reports and raw glucose observations, to support collaborative glucose management.

ALTERNATIVE NAMES

HL7 FHIR® Implementation Guide: Continuous Glucose Monitoring (CGM), Edition 1 may also go by the following names or acronyms:

"HL7 FHIR® IG: Continuous Glucose Monitoring (CGM), E1",Continuous Glucose Monitoring (CGM) (FHIR), CGM

BENEFITS

  • Enables the sharing of Continuous Glucose Monitoring (CGM) data between a patient and provider.

DEVELOPMENT BACKGROUND

The requirements for this guide were initially developed in the Argonaut Project with the input from patients, providers, CGM device vendors, app developers, and EHR systems and later in collaboration with the HL7 Orders and Observation Work Group

RELATED DOCUMENTS

HL7 FHIR® Implementation Guide: Continuous Glucose Monitoring (CGM), Edition 1

STU DOCUMENTS

HL7 FHIR® Implementation Guide: Continuous Glucose Monitoring (CGM), Edition 1 See the standard at http://hl7.org/fhir/uv/cgm/STU1. (Submit Feedback on STU)

TOPIC

  • Laboratory

BALLOT TYPE

  • STU

STATUS DATE

2025-09-24

RESPONSIBLE WORK GROUP

Orders and Observations

PRODUCT TYPE

  • Implementation Guide

STAKEHOLDERS

  • EHR, PHR Vendors
  • Equipment Vendors
  • Health Care IT Vendors
  • Healthcare Institutions
  • HIS Vendors

FAMILY

  • FHIR

CURRENT STATE

  • Active

REALM

  • Universal